Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Gunn

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Synthesis and structure-activity relationships of pyridine-modified analogs of 3-[2-((S)-pyrrolidinyl)methoxy]pyridine, A-84543, a potent nicotinic acetylcholine receptor agonistN H Lin, D E Gunn, Y Li, et al.
Journal of Medicinal Chemistry|September 1, 2000
Symmetrical bis(heteroarylmethoxyphenyl)alkylcarboxylic acids as inhibitors of leukotriene biosynthesisT Kolasa, D E Gunn, P Bhatia, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 1999
Structure-activity studies on a novel series of cholinergic channel activators based on a heteroaryl ether frameworkN H Lin, M A Abreo, D E Gunn, et al.
Journal of Medicinal Chemistry|February 16, 1996
Novel 3-Pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptorsM A Abreo, N H Lin, D S Garvey, et al.
Psychosomatic Medicine|January 31, 2022
Age Trends in Actigraphy and Self-Report Sleep Across the Life Span: Findings From the Pittsburgh Lifespan Sleep DatabankMeredith L Wallace, Nicholas Kissel, Martica H Hall, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 23, 1997
ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine]: I. A potent and selective cholinergic channel modulator with neuroprotective propertiesJ P Sullivan, D Donnelly-Roberts, C A Briggs, et al.
Journal of the American Medical Informatics Association : JAMIA|September 8, 2010
Developing syndrome definitions based on consensus and current useWendy W Chapman, John N Dowling, Atar Baer, et al.
Journal of Medicinal Chemistry|January 31, 1997
Structure-activity studies on 2-methyl-3-(2(S)-pyrrolidinylmethoxy) pyridine (ABT-089): an orally bioavailable 3-pyridyl ether nicotinic acetylcholine receptor ligand with cognition-enhancing propertiesN H Lin, D E Gunn, K B Ryther, et al.
Nature|December 20, 2003
A gravitationally lensed quasar with quadruple images separated by 14.62 arcsecondsNaohisa Inada, Masamune Oguri, Bartosz Pindor, et al.
Veterinary Journal (London, England : 1997)|September 8, 2019
Effect of clinical signs, endocrinopathies, timing of surgery, hyperlipidemia, and hyperbilirubinemia on outcome in dogs with gallbladder mucoceleJ A Jaffey, M Pavlick, C R Webster, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Synthesis and structure-activity relationships of pyridine-modified analogs of 3-[2-((S)-pyrrolidinyl)methoxy]pyridine, A-84543, a potent nicotinic acetylcholine receptor agonistN H Lin, D E Gunn, Y Li, et al.
Journal of Medicinal Chemistry|September 1, 2000
Symmetrical bis(heteroarylmethoxyphenyl)alkylcarboxylic acids as inhibitors of leukotriene biosynthesisT Kolasa, D E Gunn, P Bhatia, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 1999
Structure-activity studies on a novel series of cholinergic channel activators based on a heteroaryl ether frameworkN H Lin, M A Abreo, D E Gunn, et al.
Journal of Medicinal Chemistry|February 16, 1996
Novel 3-Pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptorsM A Abreo, N H Lin, D S Garvey, et al.
Psychosomatic Medicine|January 31, 2022
Age Trends in Actigraphy and Self-Report Sleep Across the Life Span: Findings From the Pittsburgh Lifespan Sleep DatabankMeredith L Wallace, Nicholas Kissel, Martica H Hall, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 23, 1997
ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine]: I. A potent and selective cholinergic channel modulator with neuroprotective propertiesJ P Sullivan, D Donnelly-Roberts, C A Briggs, et al.
Journal of the American Medical Informatics Association : JAMIA|September 8, 2010
Developing syndrome definitions based on consensus and current useWendy W Chapman, John N Dowling, Atar Baer, et al.
Journal of Medicinal Chemistry|January 31, 1997
Structure-activity studies on 2-methyl-3-(2(S)-pyrrolidinylmethoxy) pyridine (ABT-089): an orally bioavailable 3-pyridyl ether nicotinic acetylcholine receptor ligand with cognition-enhancing propertiesN H Lin, D E Gunn, K B Ryther, et al.
Nature|December 20, 2003
A gravitationally lensed quasar with quadruple images separated by 14.62 arcsecondsNaohisa Inada, Masamune Oguri, Bartosz Pindor, et al.
Veterinary Journal (London, England : 1997)|September 8, 2019
Effect of clinical signs, endocrinopathies, timing of surgery, hyperlipidemia, and hyperbilirubinemia on outcome in dogs with gallbladder mucoceleJ A Jaffey, M Pavlick, C R Webster, et al.
Pageof 10